Clintrax Global provides outsourced services for negotiating clinical trial-related contracts and budgets between biopharmaceutical, CROs and investigator sites.
WIRB-Copernicus Group® (WCG™) has acquired Clintrax Global, a services provider for negotiating clinical trial-related contracts and budgets between biopharmaceutical companies, CROs and investigator sites. Clintrax Global also manages, executes, and tracks payments between these global clinical trial participants. The acquisition allows WCG to offer clients a more comprehensive and integrated suite of study start-up solutions.
Read the full release.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Novel Agent Shows Superiority Over Placebo in Reducing Monthly Migraine Days
September 5th 2024Lu AG09222 shows promise as first-in-class medication that prevents neurogenic inflammation, vasodilation, and parasympathetic lacrimation, which are considered to be surrogate markers of migraine attacks.